Search results
Eli Lilly (LLY) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 3 months agoOn Eli Lilly's (LLY) fourth-quarter conference call, investor focus is likely to be on the sales...
Eli Lilly Partners With Amazon's Pharmacy Business: Here's Why Both Stocks Should Win From the Deal
Motley Fool via Yahoo Finance· 1 month agoThere's an old saying that "politics makes strange bedfellows." We could add that business sometimes...
Eli Lilly ordered to pay $176.5 million to Teva in U.S. migraine drug patent trial
Reuters via Yahoo Finance· 1 year agoEli Lilly & Co must pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to...
Eli Lilly's Migraine Candidate Flunks Head-To-Head Study With Pfizer's Newly Acquired Drug
Benzinga via Yahoo Finance· 10 months agoEli Lilly And Co (NYSE: LLY) announced the results of the CHALLENGE-MIG clinical trial of Emgality...
Eli Lilly (LLY) to Report Q1 Earnings: Will It Beat Estimates?
Zacks via Yahoo Finance· 1 year agoWe expect Eli Lilly & Company LLY to beat expectations when it reports first-quarter 2023 results on...
Eli Lilly (LLY) Q1 Earnings Miss, Sales Beat, '23 View Raised
Zacks via Yahoo Finance· 12 months agoEli Lilly (LLY) reports mixed results for the first quarter of 2023, missing estimates for earnings...
Eli Lilly (LLY) Q3 Earnings & Sales Top, EPS View Cut, Stock Up
Zacks via Yahoo Finance· 6 months agoEli Lilly (LLY) beats third-quarter estimates for earnings as well as sales. It cut its earnings...
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
Reuters via AOL· 7 months agoDrugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5...
Eli Lilly (LLY) Misses on Q1 Earnings, Lowers Earnings Guidance
Zacks via Yahoo Finance· 2 years agoEli Lilly's (LLY) earnings and sales miss second-quarter estimates. The company lowers its earnings...
Eli Lilly (LLY) Beats on Q1 Earnings, Ups Sales View, Stock Rises
Zacks via Yahoo Finance· 2 years agoEli Lilly and Company LLY reported first-quarter 2022 adjusted earnings per share of $2.62, which...